BlackRock Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-9,178
| Closed | -$77K | – | 4054 |
|
|
2016
Q1 | $77K | Buy |
9,178
+152
| +2% | +$1.28K | ﹤0.01% | 3222 |
|
|
2015
Q4 | $111K | Buy |
9,026
+36
| +0.4% | +$443 | ﹤0.01% | 3260 |
|
|
2015
Q3 | $547K | Sell |
8,990
-198
| -2% | -$12K | ﹤0.01% | 2986 |
|
|
2015
Q2 | $717K | Buy |
9,188
+3,726
| +68% | +$291K | ﹤0.01% | 2983 |
|
|
2015
Q1 | $371K | Buy |
5,462
+46
| +0.8% | +$3.12K | ﹤0.01% | 3065 |
|
|
2014
Q4 | $502K | Buy |
5,416
+41
| +0.8% | +$3.8K | ﹤0.01% | 3006 |
|
|
2014
Q3 | $566K | Buy |
5,375
+605
| +13% | +$63.7K | ﹤0.01% | 2894 |
|
|
2014
Q2 | $683K | Buy |
4,770
+767
| +19% | +$110K | ﹤0.01% | 2849 |
|
|
2014
Q1 | $604K | Buy |
4,003
+136
| +4% | +$20.5K | ﹤0.01% | 2829 |
|
|
2013
Q4 | $709K | Buy |
3,867
+563
| +17% | +$103K | ﹤0.01% | 2741 |
|
|
2013
Q3 | $730K | Buy |
3,304
+197
| +6% | +$43.5K | ﹤0.01% | 2656 |
|
|
2013
Q2 | $543K | Buy |
+3,107
| New | +$543K | ﹤0.01% | 2803 |
|